» Authors » Federica De Liso

Federica De Liso

Explore the profile of Federica De Liso including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 165
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Calatroni M, Conte E, Bello F, Stella M, De Liso F, Reggiani F, et al.
Nephrol Dial Transplant . 2024 Aug; 39(11):1930-1932. PMID: 39118376
No abstract available.
2.
Di Deo P, Vantaggiato C, Di Modugno A, Licari D, Savina P, Zagliani A, et al.
Clin Chem Lab Med . 2023 Aug; 62(2):e44-e47. PMID: 37531078
No abstract available.
3.
Caputi L, Boncoraglio G, Bernardi G, Ciusani E, Dantes M, De Liso F, et al.
Biomedicines . 2022 Oct; 10(10). PMID: 36289663
Rheumatoid meningitis (RM) is a rare but often aggressive neurological complication of rheumatoid arthritis. The diagnosis of RM, besides the clinical, radiological, and laboratory criteria, usually requires a cerebral biopsy....
4.
Villa L, Lerario A, Calloni S, Peverelli L, Matinato C, De Liso F, et al.
Acta Myol . 2019 Apr; 37(4):257-262. PMID: 30944904
Statin-induced necrotizing autoimmune myopathy (IMNM) is an autoimmune disorder induced by anti-3-hydroxy-3-methylglutaryl-coenzyme-A reductase (anti-HMGCR) antibodies. We performed a retrospective clinical, histological, and radiological evaluation of 5 patients with a 3-year...
5.
Calcaterra V, Larizza D, De Giuseppe R, De Liso F, Klersy C, Albertini R, et al.
Med Princ Pract . 2018 Oct; 28(1):48-55. PMID: 30278440
Objective: Patients with Turner syndrome (TS) have an unfavorable cardiometabolic profile. Hyperhomocysteinemia is a potential cardiovascular risk factor influenced by genetic and environmental factors, therapies, unbalanced diets and other lifestyle...
6.
De Liso F, Matinato C, Ronchi M, Maiavacca R
Clin Chem Lab Med . 2017 Jul; 56(1):25-31. PMID: 28731850
Primary biliary cholangitis (PBC), also known as primary biliary cirrhosis, is an autoimmune disease of the liver characterized by anti-mitochondrial antibodies (AMA) in 90%-95% of patients. The aim of this...
7.
Moroni G, Doria A, Giglio E, Tani C, Zen M, Strigini F, et al.
J Autoimmun . 2016 Aug; 74:6-12. PMID: 27496151
The aim of this multicenter study was to assess the present risk of fetal complications and the inherent risk factors in pregnant women with lupus nephritis. Seventy-one pregnancies in 61women...
8.
Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, et al.
J Autoimmun . 2016 Jul; 74:194-200. PMID: 27373903
Retrospective studies reported a high incidence of maternal complications in pregnant women with lupus. In this paper we prospectively assessed the rate of risk and the risk factors of maternal...
9.
De Liso F, Garigali G, Ferraris Fusarini C, Daudon M, Fogazzi G
Clin Chim Acta . 2015 Nov; 452:106-8. PMID: 26554520
No abstract available.
10.
Cirello V, Rizzo R, Crippa M, Campi I, Bortolotti D, Bolzani S, et al.
Eur J Endocrinol . 2015 Apr; 173(1):111-8. PMID: 25916393
Objective: The physiological persistence of fetal cells in the circulation and tissue of a previously pregnant woman is called fetal cell microchimerism (FCM). It has been hypothesized to play a...